DUBLIN, April 16, 2019 /PRNewswire/ -- The "North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product, Disease, Application, and Country" report has been added to ResearchAndMarkets.com's offering.
The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025.
The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-generation sequencing. Whereas, strict government guidelines and lack of knowledge and detailed examination is likely to have a negative impact on the growth of the market in the coming years.
Humans are never alone as they coexist with the diverse microbial species that live within and upon humans. From recent studies it has been very clear that this microbial community is essentially another organ of the body that plays a crucial role in human physiology and disease. Several basic and translational research efforts have been initiated to focus on deciphering mechanisms of microbiome function and how it benefits the human health.
Many human medical conditions (like inflammatory bowel diseases and obesity) have been closely associated with or are thought to be influenced by (asthma and diabetes) the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health.
The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome.
Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient's intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
US is anticipated to lead the adoptions of Human microbiome across the North American region through the forecast period. The application of the human microbiome are beneficial for various treatment areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune diseases and more.
To be specific with the applications of the human microbiome, it plays important role in the developments in wide range of diseases and disorders which includes cardiovascular disease, cancer, autoimmune, neurological disorders and more. Therefore, various programs are being organized in the country to grow the awareness of probiotics and prebiotics in order to enhance the human microbiome.
For instance, in February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego, by Kisaco Research that focused on 5 microbiome niches such as the gut, lung, oral, skin and vaginal and provided latest insights on microbiome research, clinical trials and collaborative partnerships.
Thus, owing to the above mentioned factors the market for the human microbiome is likely to grow with a significant growth rate in the coming forecast years.
Key Topics Covered:
Part 1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
Part 2. North America Human Microbiome Market - Key Takeaways
Part 3. North America Human Microbiome Market - Market Landscape
3.2 Market Segmentation
3.3 Pest Analysis
Part 4. North America Human Microbiome Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Prevalence of Chronic Diseases
4.1.2 Increasing Research and Development On Human Microbiome-Based Therapies
4.1.3 Rapid Adoption of Metagenomics and Next-Generation Sequencing Techniques
4.2 Key Market Restraints
4.2.1 Stringent Regulatory Framework
4.2.2 Lack of Expertise In Human Microbiome
4.3 Key Market Opportunities
4.3.1 Developing Fecal Microbiota Transplantation (Fmt) Therapies
4.4 Future Trends
4.4.1 Growing Human Microbiome Research In Drug Discovery
4.5 Impact Analysis
Part 5. Human Microbiome Market - North America Analysis
5.1 North America Human Microbiome Market Revenue Forecasts and Analysis
5.2 Market Positioning
5.3 Performance of Key Players
Yakult Honsha Co., Ltd.
5.4 Expert Opinions
Part 6. North America Human Microbiome Market Analysis - by Product
6.2 North America Human Microbiome Market, by Product, 2017 & 2025 (%)
6.3 North America Human Microbiome Market Revenue and Forecasts To 2025, by Product (US$ Mn)
6.4 Foods Market
6.5 Medical Food Market
6.6 Probiotics Market
6.7 Prebiotics Market
6.8 Drugs Market
6.9 Diagnostic Devices Market
6.10 Supplements Market
Part 7. North America Human Microbiome Market Analysis - by Disease
7.2 North America Human Microbiome Market, by Disease, 2017 & 2025 (%)
7.3 North America Human Microbiome Market Revenue and Forecasts To 2025, by Disease (US$ Mn)
7.4 Diabetes Market
7.5 Cancer Market
7.6 Autoimmune Disorders Market
7.7 Obesity Market
7.8 Mental Disorders Market
7.9 Others Market
Part 8. North America Human Microbiome Market Analysis - by Application
8.2 North America Human Microbiome Market, by Application, 2017 & 2025 (%)
8.3 North America Human Microbiome Market Revenue and Forecasts To 2025, by Application (US$ Mn)
8.4 Diagnostics Market
8.5 Therapeutics Market
Part 9. North America Human Microbiome Market Revenue and Forecasts To 2025
9.2 North America Human Microbiome Market Revenue and Forecasts To 2025 (US$ Mn)
9.3 North America Human Microbiome Market Revenue and Forecasts To 2025, by Product (US$ Mn)
9.4 North America Human Microbiome Market Revenue and Forecasts To 2025, by Disease (US$ Mn)
9.5 North America Human Microbiome Market Revenue and Forecasts To 2025, by Application (US$ Mn)
9.6 North America Human Microbiome Market Revenue and Forecasts To 2025, by Country (%)
Part 10. Human Microbiome Market -Industry Landscape
10.2 Growth Strategies In the Human Microbiome Market, 2015-2018
10.3 Organic Growth Strategies
10.3.2 Product Launch & Approvals
10.3.4 Patent and License
10.4 Inorganic Growth Strategies
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
Part 11. Human Microbiome Market - Key Company Profiles
- MicroBiome Therapeutics, LLC
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Osel Inc.
- Vedanta Biosciences, Inc.
- Metabiomics Corporate
- Synthetic Biologics, Inc.
- BiomX Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/f3hp4h
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets